US3937834A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Pharmaceutical preparations
Assignee: Novartis Corp
•
Filing: 1973-11-19
•
Granted: 1976-02-10
•
Expires: 1993-11-19
Abstract
Abstract The lens adjuster also has a fine adjustment ring (40) which remains stationary when not actively being turned by the user. A sun-wheel (1) is fixed in the lens-housing (10). The fine adjustment ring is in the form of a bridge (4) in which are mounted planetary wheels (2). …<??>A driven cog wheel (3) is rotarily positioned on the coarse adjustment ring (6) by a slip coupling (5). The planetary wheels on the bridge and engaging with the sun-wheel or driven wheel are identical. The sun wheel or driven wheel has profile correction. … <IMAGE> …
Inventors
- 👤 Alfred Hunger
- 👤 Hans-Jochen Janssen
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 05:57
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/41; A61K31/415
Claims Analysis
Total Claims: 5
Claim 1
Independent Claim
65 words
A pharmaceutical preparation for the treatment of angina pectoris and high blood pressure, containing a β-receptor blocker selected from the group consisting of 1-(2-allyloxyphenoxy)-2-hydroxy-3-isopropylaminopropane and 1-(4-indanyloxy)-2-hydroxy-3-isopropylaminopropane or a non-toxic salt thereof and an α-receptor blocker, 2-[N-(m-hydroxyphenyl)-p-toluidinomethyl]-2-imidazoline, or a non-toxic salt thereof together with a pharmacuetical carrier wherein the β-blocker and the α-blocker are in a ration of from 5 to 1 to 1 to 40.
Claim 2
Dependent Claim
65 words
A pharmaceutical preparation for the treatment of angina pectoris and high blood pressure, containing a β-receptor blocker selected from the group consisting of 1-(2-allyloxyphenoxy)-2-hydroxy-3-isopropylaminopropane and 1-(4-indanyloxy)-2-hydroxy-3-isopropylaminopropane or a non-toxic salt thereof and an α-receptor blocker, 2-[N-(m-hydroxyphenyl)-p-toluidinomethyl]-2-imidazoline, or a non-toxic salt thereof together with a pharmacuetical carrier wherein the β-blocker and the α-blocker are in a ration of from 5 to 1 to 1 to 40.
Claim 3
Dependent Claim
26 words
A pharmaceutical preparation as claimed in claim 1, containing the β-blocker and the α-blocker in a ratio from 2 to 1 up to 1 to 30.
Claim 4
Dependent Claim
49 words
A pharmaceutical preparation for the treatment of angina pectoris and high blood pressure, containing effective amounts of a β-receptor blocker selected from the group consisting of 1-(2-allyloxyphenoxy)-2-hydroxy-3-isopropylaminopropane and 1-(4-indanyloxy)-2-hydroxy-3-isopropylaminopropane or a non-toxic salt thereof and an α-receptor blocker, 2-[N-(m-hydroxyphenyl)-p-toluidinomethyl]-2-imidazoline, or a non-toxic salt thereof together with a pharmaceutical carrier.
Claim 5
Dependent Claim
49 words
A pharmaceutical preparation for the treatment of angina pectoris and high blood pressure, containing effective amounts of a β-receptor blocker selected from the group consisting of 1-(2-allyloxyphenoxy)-2-hydroxy-3-isopropylaminopropane and 1-(4-indanyloxy)-2-hydroxy-3-isopropylaminopropane or a non-toxic salt thereof and an α-receptor blocker, 2-[N-(m-hydroxyphenyl)-p-toluidinomethyl]-2-imidazoline, or a non-toxic salt thereof together with a pharmaceutical carrier.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1979-02-09 | 1979-08-11 | 1980-02-10 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1983-02-09 | 1983-08-11 | 1984-02-10 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1987-02-09 | 1987-08-11 | 1988-02-10 | $7700.00 | Window Closed / Lapsed |